February 11th-13th, 2010
Auditorium Rainier III
Principality of Monaco Under the High Patronage
of HSH Prince Albert II of Monaco

People Are Saying

“It sounds very intriguing”
- Stuart Lipton,
 Prof. and Scientific Director, Burnham Center for Neuroscience, Aging, and Stem Cell Research

"Very exciting conference"
- Susumu Tonegawa,
Nobel Laureate in Physiology or Medicine

"Congratulations... Choice of presenters is non routine and unusual which is very good!"
- Roger Guillemin,
Nobel Laureate in Physiology or Medicine

Twitter Updates


    Letter from the President

    President1
    Despite the billions of dollars spent annually to cure this disease, Alzheimer’s claims over 1 in 10 people over the age of 65 and represents a growing threat in the backdrop of an aging population. In fact, it is expected to claim over half of the people over 85 in coming years. Coincidentally, the past twenty years have seen substantial advances in the Neurosciences and allied fields. These major contributions, from the discovery of human stem cells in areas affected by Alzheimer’s to the sequencing of the Human Genome, have given rise to new tools, which are ripe for applications to the field of Alzheimer’s. It is high time to introduce researchers responsible for these findings to the Alzheimer’s community. In this spirit, we have convened some of the world’s most daring and innovative researchers to share their insights in the form of an international summit with Alzheimer’s as a leitmotiv, held in the Principality of Monaco in February 2010.

    I am grateful to Prince Albert II of Monaco, Madame Catherine Pastor of AMPA and First Lady Bernadette Chirac for the invitation to create this event and for recognizing the need to develop completely novel strategies against Alzheimer’s growing menace. Our Meeting of the Minds will be an interactive, interdisciplinary and international event at the forefront of academic, governmental and industrial research with speakers representing a confluence of fields including Stem Cell Research, Neurobiology, Artificial Intelligence, and Telemedicine.

    I look forward to welcoming you next February, for a truly world-class and unforgettable event.

    Sincerely,

    FirmaPresidente1

    Dr. Philip Low

    Founder, Chairman & CEO, NeuroVigil, Inc.
    Adjunct Professor, Stanford School of Medicine
    Visiting Professor, Massachusetts Institute of Technology